Ohta M - Search Results

1

Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.

Tanifuji A, Ohfuji S, Matsumoto K, Abe M, Komori A, Takahashi A, Kawata K, Sato K, Joshita S, Umemura T, Ueno M, Nakayama N, Kakisaka K, Arinaga-Hino T, Ito K, Kanai S, Miura R, Arizumi T, Asaoka Y, Ito T, Shimizu T, Yoshida H, Ohta M, Mizuno S, Isayama H, Morimoto Y, Mochida S, Ohira H, Tanaka A. Tanifuji A, et al. Among authors: ohta m. Hepatol Res. 2024 Jul;54(7):706-715. doi: 10.1111/hepr.14018. Epub 2024 Feb 1. Hepatol Res. 2024. PMID: 38300669

2

Bovine adrenal cytochrome P-450(11 beta)-mediated conversion of 11-deoxycortisol to 18- and 19-hydroxy derivatives; structural analysis by 1H-NMR.

Ohta M, Fujii S, Miura R, Nonaka Y, Okamoto M. Ohta M, et al. J Steroid Biochem Mol Biol. 1991 Dec;39(6):911-20. doi: 10.1016/0960-0760(91)90349-a. J Steroid Biochem Mol Biol. 1991. PMID: 1751390

3

Differences in tolerance to hypoxia/anoxia in mice of different ages.

Sato Y, Kitani K, Kanai S, Nokubo M, Ohta M. Sato Y, et al. Among authors: ohta m. Res Commun Chem Pathol Pharmacol. 1991 Aug;73(2):209-20. Res Commun Chem Pathol Pharmacol. 1991. PMID: 1784835

4

Localization, isolation and properties of three NADPH-dependent aldehyde reducing enzymes from dog kidney.

Ohta M, Tanimoto T, Tanaka A. Ohta M, et al. Biochim Biophys Acta. 1991 Jul 12;1078(3):395-403. doi: 10.1016/0167-4838(91)90162-s. Biochim Biophys Acta. 1991. PMID: 1907200

5

[Antibody response to P-fimbriae of Escherichia coli in patients with genitourinary infections].

Kanai S, Miyake K, Agata N, Ohta M, Kato N. Kanai S, et al. Among authors: ohta m. Hinyokika Kiyo. 1990 Jan;36(1):1-6. Hinyokika Kiyo. 1990. PMID: 1968696 Free article. Japanese.

6

Characterization of aldose reductase and aldehyde reductase from the medulla of rat kidney.

Ohta M, Tanimoto T, Tanaka A. Ohta M, et al. Chem Pharm Bull (Tokyo). 1990 Jun;38(6):1639-43. doi: 10.1248/cpb.38.1639. Chem Pharm Bull (Tokyo). 1990. PMID: 2119895

7

Tauro beta-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat.

Kanai S, Ohta M, Kitani K, Sato Y. Kanai S, et al. Among authors: ohta m. Life Sci. 1990;47(26):2421-8. doi: 10.1016/0024-3205(90)90486-b. Life Sci. 1990. PMID: 2263167

8

The order of hepatic cytotoxicity of bile salts in vitro does not agree with that examined in vivo in rats.

Ohta M, Kanai S, Kitani K. Ohta M, et al. Life Sci. 1990;46(21):1503-8. doi: 10.1016/0024-3205(90)90422-n. Life Sci. 1990. PMID: 2355795

9

Biliary albumin excretion induced by bile salts in rats is a pathological phenomenon.

Ohta M, Kitani K, Kanai S. Ohta M, et al. Res Commun Chem Pathol Pharmacol. 1989 Sep;65(3):373-88. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2813958

10

Correlation between the biliary excretion of ouabain and the lateral mobility of hepatocyte plasma membrane proteins in the rat--the effects of age and spironolactone pretreatment.

Kitani K, Zsolnai-Nagy I, Kanai S, Sato Y, Ohta M. Kitani K, et al. Among authors: ohta m. Hepatology. 1988 Jan-Feb;8(1):125-31. doi: 10.1002/hep.1840080124. Hepatology. 1988. PMID: 3338699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,132 results

Search Page

Filters